33.60
price up icon0.51%   0.17
after-market 시간 외 거래: 33.74 0.14 +0.42%
loading
전일 마감가:
$33.43
열려 있는:
$33.135
하루 거래량:
6.72M
Relative Volume:
1.17
시가총액:
$68.55B
수익:
$39.71B
순이익/손실:
$3.17B
주가수익비율:
9.7609
EPS:
3.4423
순현금흐름:
$6.05B
1주 성능:
-1.03%
1개월 성능:
+0.75%
6개월 성능:
-17.57%
1년 성능:
-7.16%
1일 변동 폭
Value
$33.04
$33.87
1주일 범위
Value
$33.04
$34.55
52주 변동 폭
Value
$32.83
$45.92

글락소스미스클라인 ADR Stock (GSK) Company Profile

Name
명칭
Gsk Plc Adr
Name
전화
-
Name
주소
-
Name
직원
70,200
Name
트위터
@GSK
Name
다음 수익 날짜
2024-10-30
Name
최신 SEC 제출 서류
Name
GSK's Discussions on Twitter

GSK을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Drug Manufacturers - General icon
GSK
Gsk Plc Adr
33.60 68.55B 39.71B 3.17B 6.05B 1.5382
Drug Manufacturers - General icon
LLY
Lilly Eli Co
767.76 690.46B 40.86B 8.37B -2.28B 9.25
Drug Manufacturers - General icon
NVO
Novo Nordisk Adr
85.00 377.54B 39.36B 13.79B 9.83B 3.086
Drug Manufacturers - General icon
JNJ
Johnson Johnson
144.47 347.83B 87.70B 14.68B 19.03B 6.05
Drug Manufacturers - General icon
ABBV
Abbvie Inc
175.58 310.27B 55.53B 5.12B 15.62B 2.88
Drug Manufacturers - General icon
MRK
Merck Co Inc
98.05 248.03B 63.17B 12.15B 14.84B 4.77

글락소스미스클라인 ADR Stock (GSK) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2024-11-15 다운그레이드 Deutsche Bank Buy → Hold
2024-11-12 다운그레이드 Jefferies Buy → Hold
2024-10-31 다운그레이드 Guggenheim Buy → Neutral
2024-07-08 다운그레이드 UBS Buy → Neutral
2024-05-30 개시 Goldman Neutral
2024-03-04 업그레이드 Guggenheim Neutral → Buy
2024-02-13 업그레이드 Citigroup Neutral → Buy
2024-01-23 개시 Morgan Stanley Equal-Weight
2024-01-16 재개 UBS Buy
2024-01-03 업그레이드 Jefferies Hold → Buy
2023-07-14 개시 HSBC Securities Reduce
2023-03-17 업그레이드 Deutsche Bank Hold → Buy
2023-02-27 재개 Goldman Buy
2023-01-03 다운그레이드 JP Morgan Neutral → Underweight
2022-12-05 다운그레이드 BofA Securities Neutral → Underperform
2022-11-11 다운그레이드 UBS Neutral → Sell
2022-09-15 업그레이드 Credit Suisse Underperform → Neutral
2022-09-08 다운그레이드 Jefferies Buy → Hold
2022-08-05 재개 Morgan Stanley Equal-Weight
2022-07-21 재개 Citigroup Neutral
2022-02-11 다운그레이드 DZ Bank Buy → Hold
2021-11-05 업그레이드 Barclays Underweight → Equal Weight
2021-06-24 업그레이드 Deutsche Bank Sell → Hold
2021-03-23 다운그레이드 SVB Leerink Outperform → Mkt Perform
2021-02-04 다운그레이드 Deutsche Bank Hold → Sell
2021-01-20 다운그레이드 Credit Suisse Neutral → Underperform
2021-01-15 개시 Deutsche Bank Hold
2020-11-02 업그레이드 Liberum Hold → Buy
2020-09-29 개시 Berenberg Buy
2020-02-12 다운그레이드 Shore Capital Hold → Sell
2020-01-16 다운그레이드 Barclays Equal Weight → Underweight
2019-12-02 개시 SVB Leerink Outperform
2019-11-21 업그레이드 UBS Neutral → Buy
2019-10-11 업그레이드 Cantor Fitzgerald Hold → Buy
2019-09-03 재개 Citigroup Neutral
2019-09-03 업그레이드 Societe Generale Sell → Buy
2019-08-13 재개 JP Morgan Neutral
2019-06-17 재개 Morgan Stanley Underweight
2019-03-08 다운그레이드 Shore Capital Buy → Hold
2019-02-22 다운그레이드 UBS Buy → Neutral
2019-01-14 다운그레이드 Exane BNP Paribas Outperform → Neutral
2018-12-11 재개 Jefferies Buy
2018-10-09 개시 Guggenheim Neutral
2018-08-30 다운그레이드 Liberum Buy → Hold
2018-04-04 업그레이드 Exane BNP Paribas Neutral → Outperform
2018-03-22 업그레이드 Morgan Stanley Underweight → Equal-Weight
2018-02-09 업그레이드 Kepler Reduce → Hold
모두보기

글락소스미스클라인 ADR 주식(GSK)의 최신 뉴스

pulisher
Dec 12, 2024

FDA Accepts GSK's Filing for Expanded Use of Nucala in COPD - MSN

Dec 12, 2024
pulisher
Dec 11, 2024

GSK Stock Declines 20% In 3 Months: Should You Buy, Sell Or Hold? - Barchart

Dec 11, 2024
pulisher
Dec 11, 2024

GSK Stock Declines 20% in 3 Months: Should You Buy, Sell or Hold? - Zacks Investment Research

Dec 11, 2024
pulisher
Dec 10, 2024

GSK's Blood Cancer Drug Shows Improved Survival Compared To Johnson & Johnson's Darzalex - Benzinga

Dec 10, 2024
pulisher
Dec 09, 2024

FDA Accepts GSK's Filing For Expanded Use Of Nucala In COPD - Barchart

Dec 09, 2024
pulisher
Dec 06, 2024

GSK Expands Vaccine Collaboration With Zhifei in China - MSN

Dec 06, 2024
pulisher
Dec 02, 2024

GSK Follows Rivals, to Cap Out-of-Pocket Inhaler Cost in US - MSN

Dec 02, 2024
pulisher
Dec 02, 2024

The 10 Best US Companies to Invest in Now - Morningstar

Dec 02, 2024
pulisher
Nov 28, 2024

GSK Gets EC Nod for Liquid Version of Meningococcal Vaccine Menveo - Zacks Investment Research

Nov 28, 2024
pulisher
Nov 22, 2024

10 Best Value Stocks to Buy for the Long Term - Morningstar

Nov 22, 2024
pulisher
Nov 18, 2024

5 Stocks to Buy While They’re Still Cheap After Earnings - Morningstar

Nov 18, 2024
pulisher
Nov 13, 2024

Diabetes Care Nutrition Market Report 2024 with Forecasts to 2029 - GlobeNewswire Inc.

Nov 13, 2024
pulisher
Nov 04, 2024

Weekly Upgrades and Downgrades - InvestorPlace

Nov 04, 2024
pulisher
Nov 04, 2024

The Best Defensive Stocks to Buy - Morningstar

Nov 04, 2024
pulisher
Nov 01, 2024

GSK Plc ADR (NYSE: GSK) Has Outstanding Potential - Stocks Register

Nov 01, 2024
pulisher
Oct 30, 2024

GSK Q3 Earnings Top, Stock Down on Lowered '24 View for Vaccine Sales - Yahoo Finance

Oct 30, 2024
pulisher
Oct 29, 2024

What Do Analysts Think About ICICI Bank Ltd. ADR’s (NYSE:IBN) Future? - Stocks Register

Oct 29, 2024
pulisher
Oct 25, 2024

GSK Plc ADR (GSK): An Important Analyst Insights - Stocks Register

Oct 25, 2024
pulisher
Oct 21, 2024

5 Stocks to Buy if You’re Concerned About US Market Valuations - Morningstar

Oct 21, 2024
pulisher
Oct 18, 2024

21 Best Healthcare Companies to Invest In - Morningstar

Oct 18, 2024
pulisher
Oct 16, 2024

Current share price is - GSK

Oct 16, 2024
pulisher
Oct 15, 2024

D-Wave Quantum Inc (QBTS) rating initates by B. Riley Securities - Knox Daily

Oct 15, 2024
pulisher
Oct 15, 2024

GSK's Studies On Depemokimab For Nasal Polyps Meet Primary Goals - Barchart

Oct 15, 2024
pulisher
Oct 15, 2024

Ophthalmic Disease Therapeutics Market Analysis by Age-related Macular Degeneration, Diabetic Macular Edema, & Other Retinal Disorders - GlobeNewswire Inc.

Oct 15, 2024
pulisher
Oct 15, 2024

GSK Plc ADR [GSK] is 5.59% higher this YTD. Is it still time to buy? - The DBT News

Oct 15, 2024
pulisher
Oct 14, 2024

What You Didn’t Know About General Motors Company (NYSE: GM) This Week - Stocks Register

Oct 14, 2024
pulisher
Oct 14, 2024

GSK’s Market Quandary: Decoding the Ups and Downs of 2023 - The InvestChronicle

Oct 14, 2024
pulisher
Oct 14, 2024

Before You Invest, Make Sure You Check This ADT Inc (NYSE: ADT) Analysis - Stocks Register

Oct 14, 2024
pulisher
Oct 14, 2024

What Are You Thinking About Investing In Medical Properties Trust Inc (NYSE: MPW) Stock? - Stocks Register

Oct 14, 2024
pulisher
Oct 10, 2024

Why GSK Stock Rocketed Nearly 6% Skyward on Wednesday - sharewise

Oct 10, 2024
pulisher
Oct 10, 2024

Introducing Our Rant Against GSK Plc ADR - US Post News

Oct 10, 2024
pulisher
Oct 10, 2024

GSK Posts New Data From Phase III Study on RSV Vaccine Arexvy - Zacks Investment Research

Oct 10, 2024
pulisher
Oct 09, 2024

Balance Sheet Insights: GSK Plc ADR (GSK)’s Debt-to-Equity and Long-Term Debt/Eq Ratios - The Dwinnex

Oct 09, 2024
pulisher
Oct 09, 2024

Pilgrim’s Pride Corp. (PPC) receives an Equal-weight rating from Stephens - Knox Daily

Oct 09, 2024
pulisher
Oct 09, 2024

Berenberg upgrades Carnival plc ADR (CUK) stock to a Hold - Knox Daily

Oct 09, 2024
pulisher
Oct 09, 2024

JP Morgan analysts downgrades an Underweight rating for Organon & Co. (OGN) - Knox Daily

Oct 09, 2024
pulisher
Oct 09, 2024

GSK Plc ADR (GSK) gets rating Downgrade from UBS - Knox Daily

Oct 09, 2024
pulisher
Oct 08, 2024

GSK Plc ADR (GSK) Stock: A Comprehensive 52-Week Review - The InvestChronicle

Oct 08, 2024

글락소스미스클라인 ADR (GSK) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
drug_manufacturers_general BMY
$57.33
price up icon 1.83%
drug_manufacturers_general SNY
$47.71
price up icon 0.44%
$263.38
price up icon 0.84%
drug_manufacturers_general PFE
$26.36
price up icon 2.29%
drug_manufacturers_general NVS
$97.11
price up icon 0.35%
drug_manufacturers_general MRK
$98.05
price down icon 1.48%
자본화:     |  볼륨(24시간):